Clinical trial / 2015
Pumpkin seed intake reduced lower urinary tract symptoms compared to placebo in men.
In a 12-month randomized controlled trial involving 1,431 men aged 50 to 80 years with benign prostatic hyperplasia symptoms, pumpkin seed intake (5 g twice daily) resulted in a higher response rate (58.5%) than placebo (47.3%). Pumpkin seed extract (500 mg twice daily) did not differ significantly from placebo. Both interventions were well tolerated, with pumpkin seeds producing a clinically relevant decrease in symptom scores.
- Study type
- Randomized controlled trial
- Who was studied
- 1,431 men aged 50-80 years with benign prostatic hyperplasia symptoms
- What was measured
- Response rate defined by decrease in International Prostate Symptom Score of ≥5 points
THE PAPER
Effects of pumpkin seed in men with lower urinary tract symptoms due to benign prostatic hyperplasia in the one-year, randomized, placebo-controlled GRANU study.
Vahlensieck W, Theurer C, Pfitzer E, Patz B, Banik N, Engelmann U. Urol Int, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.